CAU
WBA

Caxton Associates (UK)’s Walgreens Boots Alliance WBA Stock Holding History

Caxton Associates (UK)’s Portfolio WBA Stock Details WBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,143,287
Closed -$13.1M – 945
2025
Q2 		$13.1M Buy
1,143,287
+913,263
+397% +$10.2M 0.33% 39
2025
Q1 		$2.57M Buy
+230,024
New +$2.5M 0.09% 112

Other funds holding WBA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
PS
PayPay Securities Tokyo, Japan $2.89M AUM 12.57% 1-Year Est. Return

Caxton Associates (UK)'s WBA Position: Q3 2025 in Review

Caxton Associates (UK) sold out of Walgreens Boots Alliance (WBA) in Q3 2025, closing a stake of 1,143,287 shares — an estimated $13.1M sold.

Caxton Associates (UK) first reported a position in WBA in Q1 2025 and held it in 2 quarters. The position peaked at $13.1M in Q2 2025. 9 funds tracked by Wall St. Rank hold WBA as of Q3 2025.

  • Caxton Associates (UK) reported no remaining Walgreens Boots Alliance position as of Q3 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 1,143,287 Walgreens Boots Alliance shares in Q3 2025, an estimated $13.1M.
  • Caxton Associates (UK) first reported a position in Walgreens Boots Alliance in Q1 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Walgreens Boots Alliance position peaked at $13.1M in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2025.

Based on Caxton Associates (UK)'s 13F filing for Q3 2025, filed 17 Nov 2025.